The Origin and Evolution of Mutations in Acute Myeloid Leukemia

Cited by (1,001)

Items 301–400 of 1,001

  1. Hypermutation of the Inactive X Chromosome Is a Frequent Event in Cancer
    Jäger, Natalie, Schlesner, Matthias, Jones, David T.W., Raffel, Simon, Mallm, Jan-Philipp, Junge, Kristin M., Weichenhan, Dieter, Bauer, Tobias, Ishaque, Naveed, Kool, Marcel et al. · 2013 · Cell
  2. Glioblastoma Cells Containing Mutations in the Cohesin Component STAG2 Are Sensitive to PARP Inhibition
    Melanie L. Bailey, Nigel J. O’Neil, Derek M. van Pel, David A. Solomon, Todd A. Waldman, Philip Hieter · 2013 · Molecular Cancer Therapeutics
  3. Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation
    Lukasz P. Gondek, Gang Zheng, Gabriel Ghiaur, Amy Elizabeth Dezern, William H. Matsui, Srinivasan Yegnasubramanian, M-T Lin, Mark J. Levis, James R. Eshleman, Ravi Varadhan et al. · 2016 · Leukemia
  4. Understanding of leukemic stem cells and their clinical implications
    Xuefei Wang, Shile Huang, Ji‐Long Chen · 2017 · Molecular Cancer
  5. Driver mutations in acute myeloid leukemia
    Ashwin Kishtagari, Ross L. Levine, Aaron D. Viny · 2020 · Current Opinion in Hematology
  6. A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice
    Annalisa Mupo, Letizia Celani, Oliver M. Dovey, Jonathan L. Cooper, Carolyn S. Grove, Roland Rad, Paolo Sportoletti, Brunangelo Falini, Allan Bradley, George S. Vassiliou · 2013 · Leukemia
  7. The Impact of DNA Methylation in Hematopoietic Malignancies
    María Guillamot, Luisa Cimmino, Iannis Aifantis · 2016 · Trends in cancer
  8. Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma
    Jeffrey P. North, Justin Golovato, Charles Joseph Vaske, Zack Sanborn, Andrew Nguyen, Wei Wu, Benjamin Goode, Meredith Stevers, Kevin McMullen, Bethany E. Perez White et al. · 2018 · Nature Communications
  9. A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3 -Mutated Clones in Acute Myeloid Leukemia
    Daniela Francesca Angelini, Tiziana Ottone, Gisella Guerrera, Serena Lavorgna, Michela Cittadini, Francesco Buccisano, Marco De Bardi, Francesca Gargano, Luca Maurillo, Mariadomenica Divona et al. · 2015 · Clinical Cancer Research
  10. Quantifying ultra-rare pre-leukemic clones via targeted error-corrected sequencing
    Andrew L. Young, Terrence Neal Wong, Andrew E. O. Hughes, Sharon E. Heath, Timothy James Ley, Daniel C. Link, Todd E. Druley · 2015 · Leukemia
  11. NOTCH1 Aberrations in Chronic Lymphocytic Leukemia
    Emanuela Rosati, Stefano Baldoni, Filomena De Falco, Beatrice Del Papa, Erica Dorillo, Chiara Rompietti, Elisabetta Albi, Franca Falzetti, Mauro Di Ianni, Paolo Sportoletti · 2018 · Frontiers in Oncology
  12. Cohesin mutations alter DNA damage repair and chromatin structure and create therapeutic vulnerabilities in MDS/AML
    Zuzana Tóthová, Anne-Laure Valton, Rebecca A. Gorelov, Mounica Vallurupalli, John Michael Krill-Burger, Amie L. Holmes, Catherine C. Landers, J. Erika Haydu, Edyta Małolepsza, Christina R. Hartigan et al. · 2020 · JCI Insight
  13. Frequent Somatic Mutation in Adult Intestinal Stem Cells Drives Neoplasia and Genetic Mosaicism during Aging
    Katarzyna Siudeja, Sonya Nassari, Louis Gervais, Patricia Skorski, Sonia Lameiras, Donato Stolfa, Maria Zande, Virginie Bernard, Thomas Rio Frio, Allison J. Bardin · 2015 · Cell stem cell
  14. Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors
    Linda C. Zuurbier, Alejandro Gutiérrez, Charles Grenfell Mullighan, Kirsten Canté-Barrett, Olivier Gevaert, Johan de Rooi, Yunlei Li, Willem K. Smits, Jessica G. C. A. M. Buijs-Gladdines, Edwin Sonneveld et al. · 2013 · Haematologica
  15. Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma
    Green, Michael R., Vicente-Dueñas, Carolina, Romero-Camarero, Isabel, Long Liu, Chih, Dai, Bo, González-Herrero, Inés, García-Ramírez, Idoia, Alonso-Escudero, Esther, Iqbal, Javeed, Chan, Wing C. et al. · 2014 · Nature Communications
  16. Rapid learning for precision oncology
    Jeff Shrager, Jay Martin Tenenbaum · 2014 · Nature Reviews Clinical Oncology
  17. Leukaemia 'firsts' in cancer research and treatment
    Melvyn F. Greaves · 2016 · Nature reviews. Cancer
  18. Single cell analysis of clonal architecture in acute myeloid leukaemia
    Nicola E. Potter, Farideh Miraki‐Moud, Luca Ermini, Ian Titley, Gowri Vijayaraghavan, Elli Papaemmanuil, Peter J. Campbell, John G. Gribben, David Christopher Taussig, Melvyn F. Greaves · 2018 · Leukemia
  19. Translating insights into tumor evolution to clinical practice: promises and challenges
    Matthew W. Fittall, Peter Van Loo · 2019 · Genome Medicine
  20. Evolving concepts of tumor heterogeneity
    Victoria R. Zellmer, Siyuan Zhang · 2014 · Cell & Bioscience
  21. Cohesin in development and disease
    Silvia Remeseiro, Ana Cuadrado, Ana Losada · 2013 · Development
  22. Telomerase abrogates aneuploidy‐induced telomere replication stress, senescence and cell depletion
    Meena, Jitendra K, Cerutti, Aurora, Beichler, Christine, Morita, Yohei, Bruhn, Christopher, Kumar, Mukesh, Kraus, Johann M, Speicher, Michael R, Wang, Zhao‐Qi, Kestler, Hans A et al. · 2015 · The EMBO Journal
  23. Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia
    Bogdan Dumitriu, Xingmin Feng, Danielle Michelle Townsley, Yasutaka Ueda, Tetsuichi Yoshizato, Rodrigo T. Calado, Yanqin Yang, Yoshiyuki Wakabayashi, Sachiko Kajigaya, Seishi Ogawa et al. · 2014 · Blood
  24. ‘Latent drivers’ expand the cancer mutational landscape
    Ruth Nussinov, Chung‐Jung Tsai · 2015 · Current Opinion in Structural Biology
  25. Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity
    Samantha L. Goldman, Ciaran Hassan, Mihir Khunte, Arielle Soldatenko, Yunji Jong, Ebrahim Afshinnekoo, Christopher E. Mason · 2019 · Frontiers in Genetics
  26. Clonal selection and therapy resistance in acute leukaemias: mathematical modelling explains different proliferation patterns at diagnosis and relapse
    Thomas Stiehl, Natalia Baran, Anthony Dick Ho, Anna Marciniak-Czochra · 2014 · Journal of The Royal Society Interface
  27. Aging of hematopoietic stem cells: DNA damage and mutations?
    Bettina Moehrle, Hartmut Geiger · 2016 · Experimental Hematology
  28. Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD
    Sumeet A. Khetarpal, Arman Qamar, Alexander G. Bick, José J. Fuster, Sekar Kathiresan, Siddhartha Jaiswal, Pradeep Natarajan · 2019 · Journal of the American College of Cardiology
  29. Co-occurrence and mutual exclusivity: what cross-cancer mutation patterns can tell us
    Geniver El Tekle, Tiziano Bernasocchi, Arun M. Unni, Francesco Bertoni, Davide Rossi, Mark A. Rubin, Jean-Philippe Paul. Theurillat · 2021 · Trends in cancer
  30. Genetic mosaicism in the human brain: from lineage tracing to neuropsychiatric disorders
    Sara Bizzotto, Christopher A. Walsh · 2022 · Nature reviews. Neuroscience
  31. Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease
    Isidoro Cobo, Tiffany N. Tanaka, Christopher K. Glass, Calvin Yeang · 2021 · Current Opinion in Hematology
  32. A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations
    Liang Zhou, Yuesheng Zhang, Shucheng Chen, Maciej Kmieciak, Yun Leng, Hai Lin, Kathryn Rizzo, Catherine I. Dumur, Andrea Ferreira‐Gonzalez, Yun Dai et al. · 2014 · Leukemia
  33. Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD)
    Q-Y Sun, L-W Ding, K T Tan, Wenwen Chien, Anand Mayakonda, D-C Lin, X-Y Loh, J-F Xiao, Manja Meggendorfer, Tamara Alpermann et al. · 2016 · Leukemia
  34. The serum tryptase test: an emerging robust biomarker in clinical hematology
    Valent, Peter, Sperr, Wolfgang R, Sotlar, Karl, Reiter, Andreas, Akin, Cem, Gotlib, Jason, Horny, Hans-Peter, Arock, Michel · 2014 · Expert Review of Hematology
  35. Whole genome DNA sequencing provides an atlas of somatic mutagenesis in healthy human cells and identifies a tumor-prone cell type
    Irene Franco, Hafdis Th. Helgadottir, Aldo Moggio, Malin Larsson, Peter Vrtačnik, Anna Johansson, Nina Norgren, Pär Lundin, David Mas-Ponte, Johan Nordström et al. · 2019 · Genome biology
  36. Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia
    Hassan K. Awada, Arda Durmaz, Carmelo Gurnari, Ashwin Kishtagari, Manja Meggendorfer, Cassandra M Kerr, Teodora Kuzmanovic, Jibran Durrani, Jacob Tyler Shreve, Yasunobu Nagata et al. · 2021 · Blood
  37. Targeting chromatin complexes in fusion protein-driven malignancies
    Gerard L. Brien, Kimberly Stegmaier, Scott A. Armstrong · 2019 · Nature reviews. Cancer
  38. Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population
    Isabelle A. van Zeventer, Aniek O. de Graaf, Jonas B. Salzbrunn, Ilja Maria Nolte, Priscilla Kamphuis, Avinash G. Dinmohamed, Bert A. van der Reijden, Jan Jacob Schuringa, Joop H. Jansen, Gerwin A Huls · 2023 · Cancer Cell
  39. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients
    Ugo Testa, Francesco Lo‐Coco · 2016 · Annals of Hematology
  40. Timing somatic events in the evolution of cancer
    Clemency Jolly, Peter Van Loo · 2018 · Genome biology
  41. Understanding the molecular pathogenesis of acute promyelocytic leukemia
    Francesco Lo‐Coco, Syed K. Hasan · 2014 · Best Practice & Research Clinical Haematology
  42. Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance
    Dilana Elisabeth Staudt, Heather C. Murray, Tabitha McLachlan, Frank Alvaro, Anoop Kumar Enjeti, Nicole M. Verrills, Matthew D. Dun · 2018 · International Journal of Molecular Sciences
  43. High-throughput sequencing for noninvasive disease detection in hematologic malignancies
    Florian Scherer, David Matthew Kurtz, Maximilian Diehn, Ash A. Alizadeh · 2017 · Blood
  44. Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies
    Nicoletta Coccaro, Giuseppina Tota, Luisa Anelli, Antonella Zagaria, Giorgina Specchia, Francesco Albano · 2020 · International Journal of Molecular Sciences
  45. Germline risk of clonal haematopoiesis
    Alexander J. Silver, Alexander G. Bick, Michael Robert Savona · 2021 · Nature Reviews Genetics
  46. Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia
    Gus O. Nwosu, David M. Ross, Jason A. Powell, Stuart Maxwell Pitson · 2024 · Cell Death and Disease
  47. Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome
    Sergey I. Nikolaev, Federico Andrea Santoni, Anne Vannier, Emilie Falconnet, Emanuela Giarin, Giuseppe Basso, Alexander Hoischen, Joris Andre Veltman, Jürgen Groet, Dean Nižetić et al. · 2013 · Blood
  48. SF3B1 mutant MDS-initiating cells may arise from the haematopoietic stem cell compartment
    Syed A. Mian, Kevin Rouault‐Pierre, Alexander Smith, Thomas Seidl, Irene Pizzitola, Aytug Kizilors, Austin Gladston Kulasekararaj, Dominique A. Bonnet, Ghulam Jeelani Mufti · 2015 · Nature Communications
  49. Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation
    Steffen Boettcher, Christian Matthias Wilk, Jochen Singer, Fabian Beier, Elodie Burcklen, Christian Beisel, Mónica S. Ventura Ferreira, Elise Gourri, Christoph Gassner, Beat M. Frey et al. · 2020 · Blood
  50. Somatic genetic rescue of a germline ribosome assembly defect
    Shengjiang Tan, Laëtitia Kermasson, Christine Hilcenko, Vasileios E. Kargas, David Traynor, Ahmed Z. Boukerrou, Norberto Escudero-Urquijo, Alexandre Faille, Alexis Bertrand, Maxim Rossmann et al. · 2021 · Nature Communications
  51. Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma
    Konstantin Agelopoulos, Günther H.S. Richter, Eva Marina Schmidt, Uta Dirksen, Kristina von Heyking, Benjamin Moser, Hans‐Ulrich Klein, Udo Kontny, Martin Dugas, Kathrin Poos et al. · 2015 · Clinical Cancer Research
  52. Chromatin modifiers and the promise of epigenetic therapy in acute leukemia
    Sarah Merin Greenblatt, Stephen D. Nimer · 2014 · Leukemia
  53. Molecular and cellular mechanisms of aging in hematopoietic stem cells and their niches
    Lei Zhang, Ryan Michael Mack, Peter Breslin, Jiwang Zhang · 2020 · Journal of Hematology & Oncology
  54. Current challenges in clinical development of “targeted therapies”: the case of acute myeloid leukemia
    Elihu H. Estey, Ross L. Levine, Bob Löwenberg · 2015 · Blood
  55. Retinoic acid signaling in cancer: The parable of acute promyelocytic leukemia
    Julien Ablain, Hugues de Thé · 2014 · International Journal of Cancer
  56. Epigenomic drivers of immune dysfunction in aging
    Christine R. Keenan, Rhys S. Allan · 2018 · Aging Cell
  57. Cohesin Mutations in Cancer
    Magali De Koninck, Ana Losada · 2016 · Cold Spring Harbor Perspectives in Medicine
  58. Age-Associated TET2 Mutations: Common Drivers of Myeloid Dysfunction, Cancer and Cardiovascular Disease
    Christina K. Ferrone, Mack Blydt-Hansen, Michael J. Rauh · 2020 · International Journal of Molecular Sciences
  59. Genome-wide RNAi Screen Identifies Cohesin Genes as Modifiers of Renewal and Differentiation in Human HSCs
    Roman Galeev, Aurélie Baudet, Praveen Kumar, Alexandra Rundberg Nilsson, Björn Nilsson, Shamit Soneji, Therese Törngren, Åke Borg, Anders Kvist, Jonas Larsson · 2016 · Cell Reports
  60. Synthetic lethal interaction between the tumour suppressor STAG2 and its paralog STAG1
    Lorena Gabriela Benedetti, Matteo Cereda, LeeAnn Monteverde, Nikita Desai, Francesca D. Ciccarelli · 2017 · Oncotarget
  61. Clinical Implications of Inflammation in Acute Myeloid Leukemia
    Christian Récher · 2021 · Frontiers in Oncology
  62. Whole-exome sequencing of endometriosis identifies frequent alterations in genes involved in cell adhesion and chromatin-remodeling complexes
    Xiaolei Li, Yan Zhang, Luyang Zhao, Lingxiong Wang, Zhiqiang Wu, Qian Mei, Jing Nie, Xiang Li, Yali Li, Xiaobing Fu et al. · 2014 · Human Molecular Genetics
  63. The three-dimensional cancer genome
    M. Ryan Corces, Victor G. Corces · 2016 · Current Opinion in Genetics & Development
  64. Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals
    Isabelle A. van Zeventer, Aniek O. de Graaf, Hanneke J. C. M. Wouters, Bert A. van der Reijden, Melanie M. van der Klauw, Theo M. de Witte, Marianne A. Jonker, Luca Malcovati, Joop H. Jansen, Geert A. Huls · 2020 · Blood
  65. Accurate SNV detection in single cells by transposon-based whole-genome amplification of complementary strands
    Dong Xing, Longzhi Tan, Chi-Han Chang, Heng Li, X. Sunney Xie · 2021 · Proceedings of the National Academy of Sciences
  66. Advances for studying clonal evolution in cancer
    Li Ding, Benjamin J. Raphael, Feng Chen, Michael C. Wendl · 2013 · Cancer Letters
  67. EphA3 biology and cancer
    Peter W. Janes, Christopher I. Slape, Rae H. Farnsworth, Lakmali Atapattu, Andrew Mark Scott, Mary E. Vail · 2014 · Growth Factors
  68. Classification and risk assessment in AML: integrating cytogenetics and molecular profiling
    Matahi Moarii, Elli Papaemmanuil · 2017 · Hematology
  69. A generalized theory of age-dependent carcinogenesis
    Andrii I. Rozhok, James V. DeGregori · 2019 · eLife
  70. Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
    Michele Stanchina, Deborah Soong, Binbin Zheng-Lin, Justin M. Watts, Justin Taylor · 2020 · Cancers
  71. Somatic mutation and selection at population scale
    Andrew R. J. Lawson, Federico Abascal, Pantelis A. Nicola, Stefanie V. Lensing, Amy L. Roberts, Georgios Kalantzis, Adrian Baez‐Ortega, Natalia Brzozowska, Julia S. El-Sayed Moustafa, Dovile Vaitkute et al. · 2025 · Nature
  72. Epigenetic regulation of hematopoietic stem cell aging
    Isabel Beerman, Derrick J. Rossi · 2014 · Experimental Cell Research
  73. The 3' to 5' Exoribonuclease DIS3: From Structure and Mechanisms to Biological Functions and Role in Human Disease
    Robinson, Sophie, Oliver, Antony, Chevassut, Timothy, Newbury, Sarah · 2015 · Biomolecules
  74. Large chromosome deletions, duplications, and gene conversion events accumulate with age in normal human colon crypts
    John C. F. Hsieh, David Van Den Berg, Haeyoun Kang, Chih‐Lin Hsieh, Michael R. Lieber · 2013 · Aging Cell
  75. Repair of DNA double-strand breaks by templated nucleotide sequence insertions derived from distant regions of the genome
    Masahiro Onozawa, Zhenhua Zhang, Yoo Jung Kim, Liat Goldberg, Tamas Varga, Peter Leif Bergsagel, Walter Michael Kuehl, Peter D. Aplan · 2014 · Proceedings of the National Academy of Sciences
  76. Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia
    Andrew A. Lane, Oreofe Olukemi Odejide, Nadja Kopp, Sunhee S. Kim, Akinori Yoda, Rachel Erlich, Nikhil Wagle, Gregory Alan Abel, Scott J. Rodig, Joseph H. Antin et al. · 2013 · Leukemia
  77. Cancer stem cells: a potential target for cancer therapy
    Hong Ying Qiu, Xiaoguang Fang, Qi Luo, Gaoliang Ouyang · 2015 · Cellular and Molecular Life Sciences
  78. Murine Models of Acute Myeloid Leukaemia
    Marwa Almosailleakh, Juerg Schwaller · 2019 · International Journal of Molecular Sciences
  79. Genomic Landscapes and Clonality of De Novo AML
    Christopher A Miller, Richard K Wilson, Timothy J Ley · 2013 · New England Journal of Medicine
  80. Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers
    Christopher A. Miller, Yevgeniy Gindin, Charles Lu, Obi L. Griffith, Malachi Griffith, Dong Shen, Jeremy Hoog, Tiandao Li, David E. Larson, Mark A. Watson et al. · 2016 · Nature Communications
  81. The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells
    Patricia Macanas-Pirard, Thomas Quezada, Leonardo Navarrete, Richard Broekhuizen, Andrea V. Leisewitz, Bruno Nervi, Pablo A. Ramirez · 2017 · PLoS ONE
  82. A Single-Nucleotide Substitution Mutator Phenotype Revealed by Exome Sequencing of Human Colon Adenomas
    Sergey I. Nikolaev, Sotirios K. Sotiriou, Ioannis S. Pateras, Federico Andrea Santoni, Stavros Sougioultzis, Henrik Edgren, Henrikki Almusa, Daniel Robyr, Michel Guipponi, Janna Saarela et al. · 2012 · Cancer Research
  83. Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia
    Jianbiao Zhou · 2014 · World Journal of Stem Cells
  84. Targeting novel signaling pathways for resistant acute myeloid leukemia
    Kathleen M. Sakamoto, Steven Grant, Diana Saleiro, John D. Crispino, Nobuko Hijiya, Francis Joseph Giles, Leonidas C. Platanias, Elizabeth A. Eklund · 2014 · Molecular Genetics and Metabolism
  85. Centrosome amplification, chromosomal instability and cancer: mechanistic, clinical and therapeutic issues
    Marco Raffaele Cosenza, Alwin Krämer · 2015 · Chromosome Research
  86. Cell‐free tumour DNA testing for early detection of cancer – a potential future tool
    Gisela Barbany, Cecilia Arthur, Agne Liedén, Magnus Nordenskjöld, Richard Rosenquist, Bianca Tesi, Karin Wallander, Emma Tham · 2019 · Journal of Internal Medicine
  87. Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias
    K Wang, Marta Sánchez-Martín, X Wang, Kristina Marie Knapp, Richard P. Koche, Ly Vu, Michelle K. Nahas, Jie He, Michael Hadler, Eytan M. Stein et al. · 2016 · Leukemia
  88. SNooPer: a machine learning-based method for somatic variant identification from low-pass next-generation sequencing
    Jean-François Spinella, Pamela Mehanna, Ramon Oliveira Vidal, Virginie Saillour, Pauline Cassart, Chantal Richer, Manon Ouimet, Jasmine Healy, Daniel Sinnett · 2016 · BMC Genomics
  89. A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001
    Geoffrey L. Uy, Sumithra J. Mandrekar, Kristina M. Laumann, Guido Marcucci, Weiqiang Zhao, Mark J. Levis, Heidi D. Klepin, Maria R. Baer, Bayard L. Powell, Peter Westervelt et al. · 2017 · Blood Advances
  90. Clonal Hematopoiesis: A New Step Linking Inflammation to Heart Failure
    Yoshimitsu Yura, Soichi Sano, Kenneth X. Walsh · 2020 · JACC Basic to Translational Science
  91. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia
    Anuradha Kirtonia, Gouri Pandya, Gautam Sethi, Amit Kumar Pandey, Bhudev Chandra Das, Manoj Garg · 2020 · Journal of Molecular Medicine
  92. The cytokine-mediated crosstalk between primary human acute myeloid cells and mesenchymal stem cells alters the local cytokine network and the global gene expression profile of the mesenchymal cells
    Håkon Reikvam, Annette K. Brenner, Karen Marie Hagen, Knut Liseth, Silje Skrede, Kimberley Joanne Hatfield, Øystein Bruserud · 2015 · Stem Cell Research
  93. Clonal Analysis via Barcoding Reveals Diverse Growth and Differentiation of Transplanted Mouse and Human Mammary Stem Cells
    Long V. Nguyen, Maisam Makarem, Annaïck Carles, Michelle Moksa, Nagarajan Kannan, Pawan K. Pandoh, Peter D. Eirew, Tomo Osako, Melanie Kardel, Alice Man Sze Cheung et al. · 2014 · Cell stem cell
  94. The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia
    Francesca Gianni, Laura Belver, Adolfo A. Ferrando · 2019 · Cold Spring Harbor Perspectives in Medicine
  95. Genome Sequencing during a Patient’s Journey through Cancer
    Nangalia, Jyoti, Campbell, Peter J. · 2019 · New England Journal of Medicine
  96. Clonal hematopoiesis in the inherited bone marrow failure syndromes
    Frederick D. Tsai, Robert Coleman Lindsley · 2020 · Blood
  97. Alterations to DNMT3A in Hematologic Malignancies
    Kartika Venugopal, Yang Feng, Daniil E. Shabashvili, Olga A. Guryanova · 2020 · Cancer Research
  98. DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia
    for the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG), Verena I. Gaidzik, Daniela Weber, Peter Paschka, Anna Kaumanns, S Krieger, A Corbacioglu, Jan Krönke, Silke Kapp‐Schwoerer, Doris Maria Kraemer et al. · 2017 · Leukemia
  99. Clonal hematopoiesis as a model for premalignant changes during aging
    David P. Steensma, Benjamin L. Ebert · 2019 · Experimental Hematology
  100. Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease
    Michael Spencer Chapman, Alyssa H. Cull, Marioara Felicia Ciuculescu, Erica B. Esrick, Emily Mitchell, Hyunchul Jung, Laura O’Neill, Kirsty Roberts, Margarete A. Fabre, Nicholas Williams et al. · 2023 · Nature Medicine